| Product Code: ETC6065369 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Andorra Age-Related Macular Degeneration Market Overview |
3.1 Andorra Country Macro Economic Indicators |
3.2 Andorra Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 Andorra Age-Related Macular Degeneration Market - Industry Life Cycle |
3.4 Andorra Age-Related Macular Degeneration Market - Porter's Five Forces |
3.5 Andorra Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Andorra Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Andorra Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Andorra Age-Related Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in Andorra |
4.2.2 Technological advancements in AMD diagnosis and treatment |
4.2.3 Growing aging population in Andorra |
4.3 Market Restraints |
4.3.1 High cost of AMD treatment |
4.3.2 Limited access to specialized healthcare services in Andorra |
4.3.3 Regulatory challenges in introducing new AMD therapies in Andorra |
5 Andorra Age-Related Macular Degeneration Market Trends |
6 Andorra Age-Related Macular Degeneration Market, By Types |
6.1 Andorra Age-Related Macular Degeneration Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Eylea, 2021- 2031F |
6.1.4 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Lucentis, 2021- 2031F |
6.1.5 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Beovu, 2021- 2031F |
6.1.6 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Andorra Age-Related Macular Degeneration Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Dry AMD, 2021- 2031F |
6.2.3 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Wet AMD, 2021- 2031F |
6.3 Andorra Age-Related Macular Degeneration Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.3.4 Andorra Age-Related Macular Degeneration Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Andorra Age-Related Macular Degeneration Market Import-Export Trade Statistics |
7.1 Andorra Age-Related Macular Degeneration Market Export to Major Countries |
7.2 Andorra Age-Related Macular Degeneration Market Imports from Major Countries |
8 Andorra Age-Related Macular Degeneration Market Key Performance Indicators |
8.1 Number of AMD cases diagnosed annually in Andorra |
8.2 Adoption rate of advanced AMD diagnostic technologies in healthcare facilities |
8.3 Percentage of the aging population in Andorra receiving regular eye screenings for AMD |
9 Andorra Age-Related Macular Degeneration Market - Opportunity Assessment |
9.1 Andorra Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Andorra Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Andorra Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Andorra Age-Related Macular Degeneration Market - Competitive Landscape |
10.1 Andorra Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 Andorra Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here